CYBIN INC. current report, Q3 FY2023

Business Context and Reporting Period

Cybin Inc. filed Form 6-K as a foreign private issuer for September 2023. The filing was signed on September 25, 2023, and identifies the company’s principal executive offices in Toronto, Ontario.

The filing includes an exhibit index referencing Exhibit 99.1, a news release dated September 25, 2023; the news release content is not included in the provided filing text.

Financial Metrics

The provided filing text does not contain revenue, profit or loss, cash flow, margins, debt, liquidity, operating results, or other financial metrics.

Material Changes Versus Prior Period

The filing text does not provide information regarding changes versus a prior comparable period.

Guidance, Outlook, Risks, and Unusual Items

The filing text does not provide guidance, outlook, management commentary, risk disclosures, contingencies, or unusual items. Any relevant information may be contained in the referenced Exhibit 99.1, which is not provided.

Important Facts to Verify

  • Obtain and review Exhibit 99.1, the September 25, 2023 news release.
  • Verify whether the referenced news release contains material financial, operational, financing, clinical, or corporate developments.
  • Review subsequent filings for any disclosures relating to the matters announced in the exhibit.